Obesity News and Research

Latest Obesity News and Research

Study identifies key risk factors driving MASLD across populations

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population.

23 Apr 2026

Endoscopic procedure may prevent weight regain after GLP-1 discontinuation

An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid regaining the pounds they shed, according to a study to be presented at Digestive Disease Week (DDW) 2026.

23 Apr 2026

Specific intestinal fungi play role in the pathogenesis of MASLD and cardiovascular disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for cardiovascular disease (CVD). While gut bacteria have been linked to CVD, the role of intestinal fungi in subclinical coronary atherosclerosis (SCA) remains unclear.

23 Apr 2026

Microplastics in the liver may drive global liver disease rates

There is considerable evidence that microplastics and nanoplastics are present in the livers of humans, and wild animal populations on land and in the ocean.

23 Apr 2026

Tirzepatide significantly reduces cardiovascular risk in high-risk patients

Two new studies show that tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), significantly reduces cardiovascular risk in high-risk patients, including those undergoing percutaneous coronary intervention (PCI) and those with obesity undergoing transcatheter aortic valve replacement (TAVR).

23 Apr 2026

Yoga may improve cardiometabolic health in overweight adults

Practicing yoga could help people with overweight or obesity improve their cardiometabolic health, according to a study published April 22 in the open-access journal PLOS Global Public Health by Widya Wasityastuti from the University of Edinburgh, Scotland, and colleagues.

22 Apr 2026

Tirzepatide vs. semaglutide: Study compares cost and health outcomes in obesity

In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total costs and better health outcomes than semaglutide for adults with obesity or overweight without type 2 diabetes.

22 Apr 2026

Researchers identify high rates of untreated hypertension in young veterans

Approximately half a million post-9/11 U.S. veterans who served in the military have had high blood pressure, and among them, about half were undiagnosed and one quarter were untreated, according to a new study published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

22 Apr 2026

Prediabetes leaves lasting fat tissue changes after bariatric surgery

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery more difficult, according to new research being presented at this year's European Congress on Obesity (ECO) in Istanbul, Turkey (12-15 May).

22 Apr 2026

Supportive relationships in childhood help buffer the long-term health effects of abuse

A consistent, caring adult during childhood can make a profound difference for child survivors of physical or sexual abuse.

21 Apr 2026

High-fat, low-carbohydrate diet may improve beta-cell function in patients with type 2 diabetes

People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society.

21 Apr 2026

NHS grant funds study on the use of weight-loss drugs for treating PCOS

Dr. Shagaf Bakour, a gynecologist and director of medical education at Aston Medical School, has won an NHS research grant to investigate the use of weight-loss drugs in the treatment of polycystic ovary syndrome (PCOS).

21 Apr 2026

Rising colorectal cancer rates in young Swiss adults spark concern

While the incidence of colorectal cancer is decreasing among those over 50, it is rising at an alarming rate among younger individuals, sometimes as early as their thirties.

21 Apr 2026

Eating oranges daily may shift lipid patterns in fatty liver disease

A 4-week trial on 'Navelina' oranges shows potential effects on lipid metabolism in fatty liver disease, revealing intriguing but non-significant patterns.

20 Apr 2026

Visceral fat strongly linked to urinary incontinence in women

The accumulation of fat in the abdominal region, especially visceral fat (fat that accumulates between organs), significantly increases the risk of stress urinary incontinence in women.

17 Apr 2026

Women using GLP-1 drugs face higher weight loss stigma

In a new study exploring stigma associated with the use of GLP-1 drugs for weight loss, women who lost weight using GLP-1 medications were judged more harshly than those who lost weight through diet and exercise, with negative reactions driven largely by beliefs that medication-assisted weight loss is a "shortcut."

17 Apr 2026

Obesity, GLP-1s, and metabolic care

An interview with Professor Thomas Forst, Chief Medical Officer, hVIVO

From hVIVO 17 Apr 2026

A single sauna session boosts immune cells within minutes

New research shows Finnish sauna sessions rapidly mobilize immune cells, revealing heat stress effects on cytokines and potential health benefits.

17 Apr 2026

Ultra-processed diets may harm muscle health

Ultra-processed food diets may impair muscle health, with MRI findings showing increased fat infiltration in individuals at risk for knee osteoarthritis.

17 Apr 2026

Researchers debunk the existence of the childhood "adiposity rebound" phenomenon

In new research to be presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) and published in The Journal of Nutrition, a 42-year old theory as to why children's body mass index (BMI) decreases post-infancy before then rising continuously from age six years –'the adiposity rebound' is refuted using new analyses – rather than decreasing body fat, the real reason is proposed as increasing muscle mass.

17 Apr 2026